RxDoctor Payments Data

Daniel Terveen, MD

Ophthalmology · Sioux Falls, SDNPI 1053791715

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $509,596 of the $520,593 with a category attached, or 97.9%. Glaukos Corporation accounts for 98.8% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2023 at $512,816 and has fallen 99.7% since, to $1,353 in 2025. Among ophthalmology clinicians in SD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$520,593in general payments, 2019–2025

Across 161 payments — averaging $3233.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Glaukos Corporation$514K
  • Alcon$4K
  • Sight Sciences, Inc.$330
  • Oyster Point Pharma, Inc.$272
  • AbbVie$268
  • Ocular Therapeutix, Inc.$244
  • plus $2K from 17 others
$537,853in research payments, 2019–2025

Across 19 payments — averaging $28,308 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Alcon Research LLC$390K
  • Sight Sciences, Inc.$80K
  • Ocular Therapeutix, Inc.$67K

What the payments were for

  • Consulting fees$3,9061%
  • Speaking & faculty fees$509,59698%
  • Travel & lodging$1,0310%
  • Food & beverage$6,0591%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$520,593 in reported general payments places this provider in the 95th percentile of 52 ophthalmology providers in South Dakota.

See all ophthalmology providers in South Dakota

Medicare billing

Part B allowed, 2024
$456,761
Medicare patients
533
Services billed
1,713

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate107$4,209
MoxifloxacinMoxifloxacin Hcl69$1,640
Diclofenac Sodium28$324

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Sioux Falls

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →